Bacterial biofilm formation and treatment in soft tissue fillers. - Wikidata - wikimedia - TriplyDB

Bacterial biofilm formation and treatment in soft tissue fillers.

Bacterial biofilm formation and treatment in soft tissue fillers.

http://www.wikidata.org/entity/Q43757030

about

Delayed granulomatous reactions to facial cosmetic injections of polymethylmethacrylate microspheres and liquid injectable silicone: A case series.The Liquid Lift: Looking Natural Without Lumps.Global Aesthetics Consensus: Avoidance and Management of Complications from Hyaluronic Acid Fillers-Evidence- and Opinion-Based Review and Consensus Recommendations Biofilms in wounds: a review of present knowledge.Consensus statement on prevention and management of adverse effects following rejuvenation procedures with hyaluronic acid-based fillers.The increasing relevance of biofilms in common dermatological conditions.Are biofilms responsible for the adverse effects experienced following soft-tissue fillers?Skin bacterial flora as a potential risk factor predisposing to late bacterial infection after cross-linked hyaluronic acid gel augmentation.Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin.

P2860

Q35886667-6126CF28-C211-4ECD-BB6A-C40281A1DA5F Q36280789-720C1829-B3B6-40AD-AB86-F176F5F0D212 Q37591886-3FB65055-39E8-4648-95A1-8E93EC1FA2B8 Q38265634-BE84ABAC-B73E-435E-9C52-917DDA12D03B Q39267116-0F2E6778-D6A7-43BC-9EF1-C5236C620458 Q40117249-4EFAA9D4-4A8F-48F8-9644-70C07F14DFFB Q48760445-A7D964D3-5D01-4249-9758-6B95777E7775 Q54266133-3BAC757F-CE8B-4B59-BB3B-92E6C47BDD64 Q55030078-E8F62F7C-32E5-4FA3-AF73-542E908E02B2

P2860

Bacterial biofilm formation and treatment in soft tissue fillers.

http://www.wikidata.org/entity/Q43757030

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Bacterial biofilm formation and treatment in soft tissue fillers.

@en

Bacterial biofilm formation and treatment in soft tissue fillers.

@nl

type

label

Bacterial biofilm formation and treatment in soft tissue fillers.

@en

Bacterial biofilm formation and treatment in soft tissue fillers.

@nl

prefLabel

Bacterial biofilm formation and treatment in soft tissue fillers.

@en

Bacterial biofilm formation and treatment in soft tissue fillers.

@nl

P1433

Q43757030-E7758350-243E-4DED-9DDE-D58A6A9DA22A

P1476

Q43757030-282F45DF-3B7F-41E0-B3CE-570C93E31532

P2093

Q43757030-4E48B476-DBC4-450B-ABF9-39A1CA5C869D

Q43757030-7A7B10C9-F44C-4535-8002-8B84545BEFAC

Q43757030-9A32EFEC-78B2-4CDD-A649-646D5D2189B0

Q43757030-B4F4F65F-8C3C-4418-AD93-E81543D54B7A

Q43757030-C3C2BE23-5C4E-4666-9A6B-2B64EF6F0CB2

Q43757030-CDC821CA-36C7-4DAC-A565-B44C11D6FE9A

Q43757030-D68C2FBC-71FF-4C2B-A1DA-1A971413A9DE

P2860

Q43757030-009763DB-AE7D-4CB9-A22F-3E5E630BB55D

Q43757030-01D848EB-DED5-4885-8F97-FDAEB860215C

Q43757030-064B1D69-3096-4DC5-9090-310F672297F5

Q43757030-1C1136E1-8074-4A13-B4E3-FF86C0CA574F

Q43757030-1C76C32F-87CD-45CB-9ABE-9B9EB8A76B8E

Q43757030-1C7B2786-650F-4B86-BE31-D632DBFD5459

Q43757030-46B016EB-64FA-462A-99A3-CA156B64869F

Q43757030-4ECC1341-39F1-450C-8BDC-6C4C363E30A3

Q43757030-54F9D30E-94C9-4F4C-AA93-54884A9D223F

Q43757030-686C881A-8B91-4B79-BF8C-7564C7341B5D

P304

Q43757030-8498E956-BB99-4315-9927-F989084E6128

P31

Q43757030-4F41367A-9893-4F82-AAF6-E71B05EA84DB

P356

Q43757030-B861D38C-1697-4245-9192-F006FE342D83

P433

Q43757030-744695D8-17E5-4BBF-ACC1-A069F4DF96DA

P478

Q43757030-C7230165-871E-4EDF-9824-BA64EC7D6157

P50

Q43757030-17EDDD5F-5850-44D7-9B86-2E4DC637C7E4

Q43757030-4BDBA953-2372-48D0-9727-32A982D68268

Q43757030-8FD410CC-4C9E-4196-B6BF-3FC90D4C4923

Q43757030-D42979DC-1200-4B55-9751-22CAC181BC5D

Q43757030-F5DF6E22-603E-4E72-A111-35AD2C803001

P577

Q43757030-C7E97022-24A5-4120-87A2-F18F9A9EFA42

P5875

Q43757030-930FCF0B-CF37-4F41-85A2-177E33B75794

P698

Q43757030-C9F0A5B1-ADD5-4975-8378-78BBB79348B1

P921

Q43757030-6CB9ED8F-053A-497E-AC07-9871B219D36A

P356

2049-632X.12139

P1433

Pathogens and disease

P1476

Bacterial biofilm formation and treatment in soft tissue fillers

@en

P2093

Lise H Christensen

http://www.w3.org/2001/XMLSchema#string

Louise Dahl Christensen

http://www.w3.org/2001/XMLSchema#string

Maria Alhede

http://www.w3.org/2001/XMLSchema#string

Michael Tvede

http://www.w3.org/2001/XMLSchema#string

Morten Alhede

http://www.w3.org/2001/XMLSchema#string

Steffen Eickhardt

http://www.w3.org/2001/XMLSchema#string

Özge Er

http://www.w3.org/2001/XMLSchema#string

P2860

Injectable skin fillers.

The current state of treatment of adverse reactions to injectable fillers.

Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm.

The history of substances for soft tissue augmentation.

Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.

Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes.

Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes.

The minimal approach: an innovation in facial cosmetic procedures.

Adverse reactions to injectable soft tissue permanent fillers.

Long-term absorption of poly-L-lactic Acid interference screws.

P304

339-346

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/2049-632X.12139

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

Michael Givskov

Thomas Bjarnsholt

Kasper N. Kragh

Steen S. Poulsen

P577

2014-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259989671

http://www.w3.org/2001/XMLSchema#string

P698

24482426

http://www.w3.org/2001/XMLSchema#string

P921